Functional characterization of tachykinin NK1 receptors in the mouse uterus
Open Access
- 1 December 2002
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 137 (8) , 1247-1254
- https://doi.org/10.1038/sj.bjp.0704996
Abstract
1. Contractility studies were undertaken to determine the nature of the receptors mediating responses to tachykinins in uteri of oestrogen-treated mice. 2. In the presence of thiorphan (3 microM), captopril (10 microM), and bestatin (10 microM), substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) produced concentration-related contractions of uterine preparations. The order of potency was SP > or =NKA>NKB. 3. Neither atropine (0.1 microM) nor l-NOLA (100 microM), nor indomethacin (10 microM) alone or in combination with either ranitidine (10 microM) or mepyramine (10 microM), affected responses to SP. These findings indicate that SP actions are not mediated or modulated through the release of acetylcholine, nitric oxide, prostanoids or histamine. 4. In the presence of peptidase inhibitors, the tachykinin NK(1) receptor-selective agonist [Sar(9)Met(O(2))(11)]SP, produced a concentration-dependent contractile effect. The tachykinin NK(2) and NK(3) receptor-selective agonists [Lys(5)MeLeu(9)Nle(10)]NKA(4-10) and [MePhe(7)]NKB were relatively inactive. The potencies of SP analogues in which Glu replaced Gln(5) and/or Gln(6) were similar to that of SP. 5. The tachykinin NK(1) receptor-selective antagonist, SR140333 (10 nM), alone or combined with the tachykinin NK(2) receptor-selective antagonist, SR48968 (10 nM), shifted log concentration curves to SP, NKA and NKB to the right. SR140333 (10 nM) reduced the effect of [Sar(9)Met(O(2))(11)]SP. SR48968 did not affect responses to SP or [Sar(9)Met(O(2))(11)]SP, but reduced the effect of higher concentrations of NKA and shifted the log concentration-response curve to NKB to the right. The tachykinin NK(3) receptor-selective antagonist, SR 142801 (0.3 microM), had little effect on responses to SP and NKB. 6. We conclude that the tachykinin NK(1) receptor mediates contractile effects of SP, NKA and NKB and [Sar(9)Met(O(2))(11)]SP in myometrium from the oestrogen-primed mouse. The tachykinin NK(2) receptor may also participate in the responses to NKA and NKB.Keywords
This publication has 42 references indexed in Scilit:
- Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonistPublished by Elsevier ,2005
- Mechanisms underlying the neurokinin A-induced contraction of the pregnant rat myometriumBritish Journal of Pharmacology, 2000
- Stress Triggered Abortions Are Associated With Alterations of Granulated Cells in the DeciduaAmerican Journal of Reproductive Immunology, 1997
- Stress-Induced Murine Abortion Associated with Substance P-Dependent Alteration in Cytokines in Maternal Uterine Decidua1Biology of Reproduction, 1995
- The mammalian tachykinin receptorsGeneral Pharmacology: The Vascular System, 1995
- SR 142801, The first potent non-peptide antagonist of the tachykinin NK3 receptorLife Sciences, 1994
- SR 140333, a Novel, Selective, and Potent Nonpeptide Antagonist of the NK1 Tachykinin Receptor: Characterization on the U373MG Cell LineJournal of Neurochemistry, 1994
- Mammalian tachykinins stimulate rat uterus by activating NK-2 receptorsPeptides, 1993
- A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptorLife Sciences, 1992
- The sensory-efferent function of capsaicin-sensitive sensory neuronsGeneral Pharmacology: The Vascular System, 1988